Genprex Inc. (GNPX)
NASDAQ: GNPXHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 3.06 +11.27%
GNPX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $2.25M
- EPS (TTM)
- -$9.35
- Dividend yield
- None
- 52-week range
- 2.53 – 1,210.00
- Day range
- 2.66 – 2.81
- Volume / Avg
- 233.57K / 247.06K
- Beta
- —
- Shares outstanding
- 819.71K
52-week range
GNPX stock today
Shares of Genprex (GNPX) finished higher on Oct 8 at $2.75, a gain of 4.96% or $0.13 per share, versus the S&P 500's 0.47% decline. Shares are 99.8% below their 52-week high of $1,210.00 and 8.7% above the 52-week low of $2.53, near the bottom of the past year's range. Genprex has posted a net loss over the last twelve months (EPS of -$9.35), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Genprex
Company profileGenprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Ryan M. Confer M.S.
- Headquarters
- Austin, TX
- Employees
- 13
- IPO year
- 2018
- Website
- genprex.com
Genprex peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| TCRTAlaunos Therapeutics Inc. | 0.781 | -6.70% | $2.29M | vs GNPX |
| PPBTPurple Biotech Ltd. ADR | 1.44 | -1.37% | $2.34M | vs GNPX |
| OGENOragenics Inc. | 0.463 | -7.38% | $2.09M | vs GNPX |
| ELABPMGC Holdings Inc. | 3.13 | -2.04% | $2.53M | vs GNPX |
| VBIOValion Bio Inc. | 2.21 | +0.91% | $1.96M | vs GNPX |
| SPRCSciSparc Ltd. | 4.43 | -4.53% | $2.57M | vs GNPX |
| BRTXBioRestorative Therapies Inc. | 1.89 | -15.63% | $2.61M | vs GNPX |
| LABTLakewood-Amedex Biotherapeutics Inc. | 0.792 | -6.80% | $1.88M | vs GNPX |
Indexes, lists and sector
Appears in lists
Genprex stock FAQ
What is Genprex's stock price today?
GNPX last traded at $2.75 as of Oct 8, 4:00 PM EDT, up 4.96% on the day. Prices are delayed at least 15 minutes.
Who is Genprex's CEO?
Mr. Ryan M. Confer M.S. is the chief executive officer of Genprex Inc., which has about 13 employees.
What is the GNPX 52-week high?
The 52-week high for GNPX is $1,210.00 and the 52-week low is $2.53. The stock is currently 99.8% below its high.